Health
Trial started for vaccine against one of the scariest coronavirus variants – Ars Technica
The vaccine is being developed “out of an abundance of caution,” Fauci says.
Enlarge/ A vial of the current Moderna COVID-19 vaccine.
58 with 46 posters participating
View more stories
Researchers have given out the first jabs of a tweaked version of Modernas COVID-19 vaccine, one aimed at fighting one of the most concerning coronavirus variantsthe B.1.351 variant, first identified in South Africa.
The jabs are part of an early trial of the tweaked vaccine, which is being run by the NIHs National Institute of Allergy and Infectious Diseases (NIAID). The agency aims to enroll…
-
Business17 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News17 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Business21 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business20 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025